Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-2765

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2765 9)

Label for Atorvastatin Calcium 80 mg tablets by NuCare Pharmaceuticals, Inc. The label includes NDC 68071-2765-9 and indicates a bottle with 90 tablets. It specifies prescription use only and storage at controlled temperatures of 68-77°F. The label also references manufacturer details and contains batch and expiration information.*

FDA Label Image

Figure-01 (Figure 01)

A line graph comparing cumulative incidence percentages over approximately 3.5 years between Atorvastatin and placebo groups. Atorvastatin shows a lower cumulative incidence than placebo. The graph includes a hazard ratio (HR) of 0.64 with confidence intervals and a p-value of 0.0005, indicating a statistical analysis result.*

FDA Label Image

Figure-02 (Figure 02)

A line graph showing cumulative hazard percentage over time (years) up to 5 years. It compares the placebo group (dashed line) and atorvastatin group (solid line) in terms of time to first primary endpoint through four years of follow-up. The graph includes a hazard ratio (HR) of 0.63 with a confidence interval (0.48-0.83) and a p-value of 0.001.*

FDA Label Image

Figure-03 (Figure 03)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time (up to 5 years) between two Atorvastatin doses: 10 mg and 80 mg. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The 80 mg dose group shows a lower event rate over time compared to the 10 mg group, with a hazard ratio of 0.78 (95% CI 0.69-0.89), indicating statistical significance (P=0.0002).*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of Atorvastatin Calcium depicted with molecular components including calcium ions and associated functional groups as shown in the labeling image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.